Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overexpression of HER-2/neu in uterine serous papillary cancer.
Santin AD, Bellone S, Gokden M, Palmieri M, Dunn D, Agha J, Roman JJ, Hutchins L, Pecorelli S, O'Brien T, Cannon MJ, Parham GP. Santin AD, et al. Clin Cancer Res. 2002 May;8(5):1271-9. Clin Cancer Res. 2002. PMID: 12006548
Current treatment options for endometrial cancer.
Santin AD, Bellone S, O'Brien TJ, Pecorelli S, Cannon MJ, Roman JJ. Santin AD, et al. Expert Rev Anticancer Ther. 2004 Aug;4(4):679-89. doi: 10.1586/14737140.4.4.679. Expert Rev Anticancer Ther. 2004. PMID: 15270671 Review.
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S. Santin AD, et al. Int J Cancer. 2004 Oct 20;112(1):14-25. doi: 10.1002/ijc.20408. Int J Cancer. 2004. PMID: 15305371 Free article.
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Bellone S, et al. Cancer. 2009 Feb 15;115(4):800-11. doi: 10.1002/cncr.24048. Cancer. 2009. PMID: 19117353 Free article.
Immunological treatment of ovarian cancer.
Cannon MJ, Santin AD, O'Brien TJ. Cannon MJ, et al. Curr Opin Obstet Gynecol. 2004 Feb;16(1):87-92. doi: 10.1097/00001703-200402000-00015. Curr Opin Obstet Gynecol. 2004. PMID: 15128013 Review.
3,528 results